Medicare recipients are facing unprecedented increases in their prescription drug costs, with some medications nearly ...

A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often ...

UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.

By Catalina Jaramillo and Kate Yandell In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in half or more “almost immediately.” But ...

The Rhode Island Senate on Thursday (May 15) approved legislation (2025-S 0468aa) sponsored by Senate Finance Committee ...

President Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making the ...

Emphasizes that the United States aims to provide access to prescription drugs at lower costs for US patients and taxpayers, ...

More than 14 million poor Medicare beneficiaries receive the Medicare Part D Low-Income Subsidy (LIS), which further reduces ...

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US ...

President Trump signed two executive orders concerning drug access and affordability, including for biologics and ...

While much of Washington, DC’s attention this week has been focused on congressional action around budget reconciliation, ...